Seres Therapeutics (MCRB) announced the appointment of Thomas DesRosier and Marella Thorell as co-Chief Executive Officers. This appointment will follow the departure of Chief Executive Officer Eric Shaff on July 31, 2025, after a decade with the Company, to pursue a new professional opportunity. Shaff will continue to serve as a Director on the Seres Board. DesRosier and Thorell will retain responsibilities related to their roles as Chief Legal Officer and Chief Financial Officer, respectively.
Claim 70% Off TipRanks Premium
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on MCRB: